Brief: Cardiff Oncology Announces $15 Million Equity Investment From Pfizer Through Its Pfizer Breakthrough Growth Initiative
18/11/2021 12:28
Nov 18 (Reuters) - Cardiff Oncology Inc CRDF.O :
* CARDIFF ONCOLOGY ANNOUNCES $15 MILLION EQUITY INVESTMENT
FROM
PFIZER THROUGH ITS PFIZER BREAKTHROUGH GROWTH INITIATIVE
* CARDIFF ONCOLOGY INC - PFIZER PURCHASED 2.4 MILLION SHARES
OF
CARDIFF ONCOLOGY AT $6.22 PER SHARE
Source text for Eikon: ID:nPnbH8q0La
Further company coverage: CRDF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering